Impact of QoLibri Medical Device on the Consequences of Chronic Pain: a Randomized Controlled Trial

Recruiting N/A Interventional Study
Chronic Pain
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
410 (estimated)
Sponsor
Novesia · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
A superiority study evaluating the impact of the QoLibri Software as Medical Device on functional and psychological consequences of chronic pain in primary care patients. A prospective, cluster-randomized, wait list, controlled multicentre study with the main objective of evaluating the effectiveness of the QoLibri Digital Therapy on Quality of Life improvement in patients living with chronic pain…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient experiencing at least moderate pain (on the Categorical Pain Scale) for more than 3 months * Patient with a BPI interference score ≥ 3 in at least 3 out of 7 dimensions * Patient with a smartphone and an internet connection at the place of use * Patient affiliated with…
Contacts

Alice Corteval, PharmD

+33 6 88 08 29 72

a.corteval@novesia.fr

CONTACT

Géraldine Batot, PhD

geraldine.batot@kyomed.com

CONTACT